English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduCan we eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable populations? A new study shows the feasibility of offering high-risk communities free, accessible testing and treatment for H.pylori infection – a major risk factor for gastric cancer.
Tag: Gastric Cancer
Clinical Trial Results Published in Nature Medicine Show Immunotherapy’s Potential in Resectable Esophageal and Gastroesophageal Junction Cancers and the Benefits of Monitoring Circulating Tumor DNA (ctDNA) to Measure Disease Response
The results of a study published today in Nature Medicine show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy. The study results also show the potential for monitoring circulating tumor DNA as a predictor for future intervention.
5G-Enabled Robotic Surgery—A New Era in Gastric Cancer Treatment
In a groundbreaking medical procedure, researchers have utilized 5G communication technology to perform the world’s first robot-assisted radical distal gastrectomy remotely without intraoperative or postoperative complications.
Baylor Scott & White Shares Insights At ACG Annual Scientific Meeting 2023
The 2023 American College of Gastroenterology (ACG) Annual Scientific Meeting & Postgraduate Course will convene in Vancouver, Canada, Oct. 20-25. The ACG is a recognized leader in educating GI professionals and the public about digestive disorders. The ACG’s mission is…
New single-cell study provides novel insights into gastric cancer
A single-cell study led by MD Anderson researchers and published in Cancer Cell provides a deeper understanding of the evolution of the tumor microenvironment during gastric cancer progression.
MD Anderson Research Highlights for March 29, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
The Role of H. pylori in Gastric Cancer
Helicobacter pylori (H. pylori) infection is a major cause of gastric cancer, and researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have several projects underway to better understand the association and develop much-needed prevention and treatment.
Magic Traditional Chinese Medicine Ingredients Generated Autophagic Flux to Suppress Tumor Progression and Novel Combination Therapy Strategy in Gastric Cancer
This study is led by Dr. Longtao Huangfu, and Dr. Xiaoyang Wang (Peking University Cancer Hospital & Institute). A diet of fresh fruits and vegetables may reduce the prevalence of cancers, including GC (Eusebi et al., 2020; Liu et al., 2021).
Study on Green Kiwifruit to Treat Chronic Constipation and New ACG Clinical Guidelines on C. difficile Infection Featured in the June Issue of The American Journal of Gastroenterology
The June issue of AJG includes articles on the effectiveness of OTC therapies and green kiwifruit as a dietary therapy for chronic constipation, as well as new ACG Guidelines on the Prevention, Diagnosis, and Treatment of C. difficile infections, and more.
Atlantic Health System Physicians Co-Author 5 Studies, Presented at American Association for Cancer Research (AACR) Annual Meeting
Atlantic Health System Cancer Care physicians are co-authors of five original studies presented at this year’s AACR Annual Meeting, held virtually April 10-15 and May 17-21. The AACR meeting is one of the world’s premier scientific gatherings of cancer specialists and researchers.
Single-cell analysis of metastatic gastric cancer finds diverse tumor cell populations associated with patient outcomes
Researchers from The University of Texas MD Anderson Cancer Center who profiled more than 45,000 individual cells from patients with peritoneal carcinomatosis (PC), a specific form of metastatic gastric cancer, defined the extensive cellular heterogeneity and identified two distinct subtypes correlated with patient survival.
Stupid Strong Charitable Foundation Pledges $250,000 to Support Gastric Cancer Research at MD Anderson Cancer Center
Stupid Strong Charitable Foundation is proud to contribute $250,000 to The University of Texas MD Anderson Cancer Center to support cutting-edge research in gastric cancer led by Jaffer Ajani, M.D., professor of Gastrointestinal Medical Oncology.
Leading Cancer Treatment Recommendations from NCCN Now Available in French, German, Italian, Portuguese, Russian, and Spanish
NCCN Guidelines, containing expert recommendations for cancer care, are available in French, German, Italian, Portuguese, Russian, and Spanish can all be accessed for free at NCCN.org/global or via the free Virtual Library of NCCN Guidelines® App
Study: surgical delay associated with increased risk in some gastrointestinal malignancies
Early in the COVID-19 pandemic, widespread cancellations of electively-scheduled or “non-emergency” operations were implemented to free up hospital beds and conserve protective equipment for health care workers. For some conditions, including cancer, timely surgery is critical for patients’ survival. In a new study published in the Journal of Gastrointestinal Surgery, a team of investigators at Beth Israel Deaconess Medical Center (BIDMC) examined the effects of delaying surgery for gastrointestinal cancers.
Advisory: Resarchers Develop Ultasensitive Blood Test to Predict Recurrence Of Gastric Cancers
Researchers at the Johns Hopkins Kimmel Cancer Center in Baltimore, working with colleagues in the Netherlands, developed a blood test that can predict recurrence of gastric cancer in patients after surgery. A description of their test, which is still experimental, was published online Jan. 27 in the journal Nature Communications.